About 5,220,000 results
Press Room - Sanofi US News
ASCO: Sarclisa is first anti-CD38 to significantly improve ... - Sanofi
Press Release: Sarclisa approved in the US as the first anti-CD38 ...
FDA Approves Sarclisa In Newly Diagnosed Transplant-Ineligible …
Sanofi moves on J&J in first-line myeloma with FDA nod
Press Room - Sanofi US News
FDA Approves Isatuximab With VRd as First-Line Option for …
FDA Approves New Therapy for Patients with Previously Treated …
Sarclisa® (isatuximab) Phase 3 trial met primary endpoint of
Sanofi Says FDA Approves Sarclisa for Treatment of Blood Cancer ...
- Some results have been removed